Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Research output: Contribution to journal › Review › Research › peer-review
| Original language | English |
|---|---|
| Journal | Therapeutic Drug Monitoring |
| Volume | 40 |
| Issue number | 1 |
| Pages (from-to) | 9-16 |
| ISSN | 0163-4356 |
| DOIs | |
| Publication status | Published - Feb 2018 |
- companion diagnostics, complementary diagnostics, drug-diagnostic codevelopment, PD-L1, immune checkpoint inhibitors, NSCLC, precision medicine
Research areas
ID: 201198293